Please login to the form below

Not currently logged in
Email:
Password:

CombiHIVvac

This page shows the latest CombiHIVvac news and features for those working in and with pharma, biotech and healthcare.

HIV vaccine from J&J starts human trials

HIV vaccine from J&J starts human trials

Scarcity of funding is also threatening a Russian HIV vaccine candidate called CombiHIVvac, which is heading for phase II testing.

Latest news

  • Russian HIV vaccine heading for phase II trials Russian HIV vaccine heading for phase II trials

    trial of CombiHIVvac still needs to be approved by the government, reports the RIA Novosti news agency. ... Mikheyev told reporters that the phase II trials planned for CombiHIVvac could take around two years to complete, provided funding can be found.

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics